128 related articles for article (PubMed ID: 1824665)
1. The effect of doxazosin on platelet aggregation in normotensive subjects and patients with hypertension: an in vitro study.
Hernandez Hernandez R; Carvajal AR; Guerrero Pajuelo J; Armas de Hernandez MJ; Armas Padilla MC; Barragan O; Boada Boada JJ; Roa E
Am Heart J; 1991 Jan; 121(1 Pt 2):389-94. PubMed ID: 1824665
[TBL] [Abstract][Full Text] [Related]
2. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
Hernández Hernández R; Angeli-Greaves M; Carvajal AR; Guerrero Pajuelo J; Armas Padilla MC; Armas-Hernández MJ
Am J Hypertens; 1996 May; 9(5):437-44. PubMed ID: 8735174
[TBL] [Abstract][Full Text] [Related]
3. Evidence of an antiplatelet aggregation action of doxazosin in patients with hypertension: an ex vivo study.
Hernandez Hernandez R; Guerrero Pajuelo JR; Carvajal AR; Armas Padilla MC; Armas de Hernandez MJ; Barragan O; Boada Boada JJ
Am Heart J; 1991 Jan; 121(1 Pt 2):395-401. PubMed ID: 1824666
[TBL] [Abstract][Full Text] [Related]
4. In vitro adrenaline and collagen-induced mobilization of platelet calcium and its inhibition by naftopidil, doxazosin and nifedipine.
Alarayyed NA; Cooper MB; Prichard BN; Betteridge DJ; Smith CC
Br J Clin Pharmacol; 1997 Apr; 43(4):415-20. PubMed ID: 9146854
[TBL] [Abstract][Full Text] [Related]
5. The potentiation of adrenaline-induced in vitro platelet aggregation by ADP, collagen and serotonin and its inhibition by naftopidil and doxazosin in normal human subjects.
Alarayyed NA; Graham BR; Prichard BN; Smith CC
Br J Clin Pharmacol; 1995 Apr; 39(4):369-74. PubMed ID: 7640142
[TBL] [Abstract][Full Text] [Related]
6. Differential actions of naftopidil, doxazosin and nifedipine on platelet thromboxane generation and platelet-derived growth factor efflux in vitro.
Alarayyed NA; Prichard BN; Betteridge DJ; Smith CC
Platelets; 2002; 13(5-6):267-71. PubMed ID: 12189011
[TBL] [Abstract][Full Text] [Related]
7. Nifedipine reduces thromboxane A2 production by platelets without changing aggregation in hypertensive pregnancy.
Manninen A
Pharmacol Toxicol; 1996 Jun; 78(6):387-91. PubMed ID: 8829198
[TBL] [Abstract][Full Text] [Related]
8. Effect of doxazosin gastrointestinal therapeutic system on platelet degranulation and platelet-leukocyte microaggregate formation induced by physiologic shear stress in hypertension.
Labiós M; Martínez M; Gabriel F; Guiral V; Aznar J
Thromb Res; 2006; 118(4):447-53. PubMed ID: 16242179
[TBL] [Abstract][Full Text] [Related]
9. A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.
Elliott HL; Meredith PA; Sumner DJ; McLean K; Reid JL
Br J Clin Pharmacol; 1982 May; 13(5):699-703. PubMed ID: 6123342
[TBL] [Abstract][Full Text] [Related]
10. Effects of prazosin on platelet aggregation and plasma beta-thromboglobulin in essential hypertension.
Ikeda T; Nonaka Y; Goto A; Ishii M
Clin Pharmacol Ther; 1985 Jun; 37(6):601-5. PubMed ID: 2408807
[TBL] [Abstract][Full Text] [Related]
11. Fosinopril reduces ADP-induced platelet aggregation in hypertensive patients.
Keidar S; Oiknine J; Leiba A; Shapira C; Leiba M; Aviram M
J Cardiovasc Pharmacol; 1996 Feb; 27(2):183-6. PubMed ID: 8720415
[TBL] [Abstract][Full Text] [Related]
12. Beta-thromboglobulin and platelet aggregation in essential hypertension and the influence of prazosin therapy.
Okrucká A; Pechán J; Mikulecký M
Cor Vasa; 1990; 32(5):363-73. PubMed ID: 2149548
[TBL] [Abstract][Full Text] [Related]
13. Platelet in vitro responses to urapidil and prazosin.
Smith CC; Betteridge DJ; Prichard BN
Drugs; 1990; 40 Suppl 4():48-51. PubMed ID: 2092966
[No Abstract] [Full Text] [Related]
14. The effect of prazosin therapy on platelet activation in essential hypertension.
Okrucká A; Pechán J; Mikulecký M
Clin Exp Pharmacol Physiol; 1990 Dec; 17(12):813-9. PubMed ID: 2151184
[TBL] [Abstract][Full Text] [Related]
15. Platelet alpha2-adrenoceptor alterations in patients with essential hypertension are normalized after treatment with doxazosin but not propranolol.
Portaluppi F; Manfredini R; Varani K; Gessi S; Caiazza A; Borea PA
J Hypertens; 2000 Feb; 18(2):217-21. PubMed ID: 10694191
[TBL] [Abstract][Full Text] [Related]
16. Effect of prazosin GITS, atenolol, nifedipine SR, and enalapril on ADP-induced platelet aggregation.
Patki KC; Joglekar SJ; Kamat SK; Thatte UM; Yeolekar ME; Rege NN; Dahanukar SA; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():26-9. PubMed ID: 11229106
[TBL] [Abstract][Full Text] [Related]
17. An open one-year comparison of doxazosin and prazosin for mild to moderate essential hypertension.
Torvik D; Madsbu HP
Am J Cardiol; 1987 May; 59(14):68G-72G. PubMed ID: 2884855
[TBL] [Abstract][Full Text] [Related]
18. ACE inhibitor effects on platelet function in stages I-II hypertension.
Moser L; Callahan KS; Cheung AK; Stoddard GJ; Munger MA
J Cardiovasc Pharmacol; 1997 Oct; 30(4):461-7. PubMed ID: 9335405
[TBL] [Abstract][Full Text] [Related]
19. Acute haemodynamic and hormonal effects of oral doxazosin in normal subjects.
Whitworth JA; Butty J; Gordon D
Clin Exp Pharmacol Physiol; 1987 Feb; 14(2):133-5. PubMed ID: 2955979
[TBL] [Abstract][Full Text] [Related]
20. Effects of isradipine on platelet function in hypertension at rest and during exercise.
Fitscha P; Virgolini I; Rauscha F; Sinzinger H
Am J Hypertens; 1991 Feb; 4(2 Pt 2):178S-180S. PubMed ID: 1827015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
